MTHFR and ALL risk: a challenge.
Toffoli
Giuseppe
G
Experimental and Clinical Pharmacology Unit, CRO National Cancer Institute, Aviano, Italy.
Innocenti
Federico
F
D000483:Alleles; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D011110:Polymorphism, Genetic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D012306:Risk
D042965:Methylenetetrahydrofolate Reductase (NADPH2)